Table 1.
Relative mRNA expression of representative Nrf2 target genes in WT, Nrf2flox/flox, Nrf2flox/flox::AlbCre and systemic Nrf2-disrupted mouse livers under basal (DMSO) and induced (7 mg/kg WA) conditions.
Gene | Wild-type | Nrf2flox/flox | Nrf2flox/flox::AlbCre | Nrf2-disrupted | ||||
---|---|---|---|---|---|---|---|---|
| ||||||||
DMSO | WA | DMSO | WA | DMSO | WA | DMSO | WA | |
Nqo1 | 1.0±0.2 | 2.9±0.2* | 1.6±0.6 | 3.1±0.3*,a | 0.7±0.1 | 1.4±0.1b | 0.1±0.02 | 0.2±0.02 |
Gclc | 1.0±0.1 | 3.4±0.9* | 1.3±0.3 | 7.7±2.1*,a | 0.9±0.3 | 3.1±0.3*,b | 1.7±0.4 | 0.6±0.2c |
Sult1a1 | 1.0±0.2 | 2.4±0.8 | 0.9±0.2 | 2.7±0.8 | 0.8±0.3 | 3.5±0.7*,b | 2.2±0.5 | 2.5±1.3 |
Gstp1 | 1.0±0.1 | 2.8±0.5* | 0.9±0.2 | 4.9±1.2*,a | 0.4±0.1 | 3.1±0.2*,b | 1.7±0.5 | 1.3±0.6 |
Ugt1a1 | 1.0±0.3 | 2.2±0.3* | 0.8±0.2 | 2.0±0.5a | 0.7±0.2 | 1.5±0.3b | 0.9±0.2 | 1.3±0.7 |
Gsta1 | 1.0±0.2 | 3.2±1.2* | 0.8±0.2 | 7.3±2.1*,a | 0.2±0.1 | 0.8±0.2 | 0.8±0.2 | 0.6±0.2 |
Gsta4 | 1.0±0.1 | 3.8±1.4* | 2.3±0.7* | 5.4±1.4* | 0.6±0.1 | 1.9±0.3b | 1.6±0.3 | 0.8±0.2 |
Gsr1 | 1.0±0.1 | 3.4±0.9* | 0.8±0.1 | 4.9±1.6*,a | 0.9±0.3 | 4.7±0.7*,b | 1.1±0.5 | 0.9±0.5 |
Nrf2 | 1.0±0.3 | 4.8±2.8* | 1.4±0.7 | 5.2±1.7*,a | 0.1±0.02 | 0.5±0.1 | ND | ND |
Values are mean ± SEM (n=3). p<0.05.
compared to WT DMSO,
compared to Nrf2flox/flox DMSO group,
compared to Nrf2flox/flox::AlbCre DMSO group,
compared to Nrf2-disrupted DMSO group.
ND: Not detected.